Is Dermorphin FDA approved?
No. This profile records Dermorphin as not FDA approved and for research use only.
MORE CONTEXT ›
Review the regulatory and source details on this page for the current context.
Longevity CATEGORY
Dermorphin
THE PAIN ELIMINATOR
Dermorphin is a powerful opioid peptide originally isolated from the skin of South American frogs. It's about 30-40 times more potent than morphine at relieving pain, and its unique structure makes it more resistant to breakdown in the body. This means smaller doses work longer, but it also carries serious risks of dependence.
Dermorphin
Dermorphin
Dermorphin
Dermorphin Evidence Snapshot
How these guides are reviewed
REGULATORY STATUS
Not FDA approved · research use only
DOSING GUIDANCE
Reviewed by our clinical team
LINKED EVIDENCE
1 research sources
CONTENT UPDATED
Aug 28, 2026
Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.
Quick Answers About Dermorphin
What dose does The Peptide App Clinical Team recommend for Dermorphin?
Dose: 0.1-1 mg daily (research only).
MORE CONTEXT ›
Schedule: daily. Cycle: Short-term use only. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.
What research supports this Dermorphin guide?
This guide links to 1 curated or current research sources.
MORE CONTEXT ›
Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.
Studied Effects & Mechanisms
Mu-Opioid Agonist
Powerful activation of pain-blocking opioid receptors
Long Duration
D-amino acids make it resistant to breakdown
Severe chronic pain patients
Those unresponsive to other pain medications
Research applications only
NOT for casual use
Dermorphin Research
Live research temporarily unavailableThe live research feed did not return papers for this page. The curated references below remain available for crawlable source context.
RESEARCH REFERENCES